Dharmesh Singh

Dharmesh Singh

Auto-generated profile, based on publicly available information

Dharmesh Singh

Central Research Institute-Global Scientific Collaboration, United Imaging Healthcare, Shanghai, China

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2025 in International Journal of Biomedical Imaging
Verified
Journal Article
Open access
ASAbhijith S.
Abhijith S.
RKRajagopal Kadavigere
Rajagopal Kadavigere
PSPriya Pattath Sankaran
Priya Pattath Sankaran
DSDharmesh Singh
Dharmesh Singh
D.Dr. Priyanka .
Dr. Priyanka .
SPSaikiran Pendem
Saikiran Pendem
Background: Intravoxel incoherent motion (IVIM) magnetic resonance imaging (MRI) is a noncontrast technique estimating diffusion and perfusion parameters via multiple b ‐values, essential for oncology imaging. However, there is limited collective evidence regarding the efficacy of IVIM in oncology imaging compared to contrast‐enhanced (CE) MRI perfusion techniques. This systematic review and meta‐analysis compared IVIM′s diagnostic accuracy and correlation with CE MRI perfusion techniques. Methods: Following PRISMA guidelines (PROSPERO‐registered), a literature search across five databases (PubMed, Scopus, Embase, Web of Science, and Cochrane Library) was conducted. Diagnostic metrics, including AUC, sensitivity, specificity, and correlation coefficients, were analyzed using a random‐effects model, with heterogeneity and publication bias assessed via I 2 statistics and Egger′s test. Results: Eighteen studies on breast, rectal, and brain cancers were analyzed. For breast cancer, IVIM showed 83.50% sensitivity and 81.24% specificity compared to dynamic contrast‐enhanced (DCE) MRI′s 88.04% sensitivity and 65.98% specificity. In rectal cancer, IVIM achieved 70.9% sensitivity and 56.2% specificity, outperforming DCE MRI′s 58.11% sensitivity and 72.49% specificity. For gliomas, IVIM demonstrated 92.27% sensitivity and 74.06% specificity compared to dynamic susceptibility contrast (DSC) MRI′s 95.71% sensitivity and 92.91% specificity. Correlations between IVIM and CE parameters were weak to moderate. Conclusion: IVIM demonstrated equal or superior diagnostic performance to CE MRI in breast cancer, rectal cancer, and gliomas, offering a noncontrast alternative. However, unclear parameter correlations warrant future studies focusing on IVIM protocol optimization based on perfusion regimes.